Implantable defibrillators with enhanced detection algorithms: Detection performance and safety results from the painfree sst study

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 9, 2014, Pages 1198-1209

  Wollmann, Christian G ^a,b   Lawo, Thomas ^c   Kühlkamp, Volker ^d   Becker, Rüdiger ^e   Garutti, Claudio ^f   Jackson, Troy ^g   Brown, Mark L ^g   Mayr, Harald ^a,b  

^a Hospital of St Pölten Lilienfeld   (Austria)

^b Karl Landsteiner Society   (Austria)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Herzzentrum Bodensee   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^g MEDTRONIC INC   (United States)

Author keywords

complications; implantable defibrillator; inappropriate shocks; shock reduction algorithm

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONVULSIVE THERAPY; DEVICE INFECTION; ENDOCARDITIS; FEMALE; HEART FAILURE; HEART INJURY; HEART PERFORATION; HEART VENTRICLE FIBRILLATION; HEMATOTHORAX; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEAD DISLODGEMENT; MAJOR CLINICAL STUDY; MALE; MARKETING; MULTICENTER STUDY; NOISE; PATIENT SAFETY; PNEUMOTHORAX; POSTOPERATIVE HEMORRHAGE; PRIMARY PREVENTION; PROSPECTIVE STUDY; PROSTHESIS FAILURE; T WAVE; TREATMENT INDICATION; VERY ELDERLY; WOUND HEALING IMPAIRMENT; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL; DEVICE SAFETY; ELECTROCARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; POSTMARKETING SURVEILLANCE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANTICOAGULANT AGENT;

AGED; ALGORITHMS; ANTICOAGULANTS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SAFETY; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84908223239     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12390     Document Type: Article

References (25)

1. Investigators A., A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The antiarrhythmics versus implantable defibrillators (avid) investigators. N Engl J Med 1997; 337: 1576-1583.
2. Luderitz B, Jung W, Deister A, Marneros A, Manz M,. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 1993; 16: 1815-1821.
3. Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, et al. Assessing the psychosocial impact of the ICD: A national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 2000; 23: 939-945.
4. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ,. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT Reduces Shock Therapies (PainFree Rx II) trial. Circulation 2005; 111: 2898-2905.
5. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFree Rx II) trial results. Circulation 2004; 110: 2591-2596.
6. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM,. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the Prospective Randomized Multicenter EMPIRIC trial. J Am Coll Cardiol 2006; 48: 330-339.
7. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52: 541-550.
8. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA, 3rd, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275-2283.
9. Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: The ADVANCE III randomized clinical trial. J Am Med Assoc 2013; 309: 1903-1911.
10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
11. Wollmann CG, Gottker U, Bocker D, Gradaus R,. Near fatal arrhythmia induction by an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2006; 17: 1026-1028.
12. Auricchio A, Meijer A, Kurita T, Schloss E, Brinkman K, Claessens-van Ooijen M, Sterns L,. Safety, efficacy and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: The PainFree SST clinical study design. Europace 2011; 13: 1484-1493.
13. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm 2008; 5: 934-955.
14. Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM,. Combining shock reduction strategies to enhance ICD therapy: A role for computer modeling. J Cardiovasc Electrophysiol 2011; 22: 280-289.
15. Cao J, Gillberg JM, Swerdlow CD,. A fully-automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to t-wave oversensing in spontaneous rhythm. Heart Rhythm 2012; 9: 522-530.
16. Winkle RA, Mead RH, Ruder MA, Smith NA, Buch WS, Gaudiani VA,. Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. Circulation 1990; 81: 1477-1481.
17. Farooqi F, Kamdar R, Adhya S, Bayne S, Jackson T, Pollock L, Sterns L, et al. First clinical experience with an automatic algorithm to prevent inappropriate shocks due to t-wave oversensing in ICDs. Abstract. Europace 2011; 13 (suppl 1): i81.
18. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH,. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol 2008; 1: 240-249.
19. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW,. Complications leading to surgical revision in implantable cardioverter defibrillator patients: Comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 2009; 11: 297-302.
20. Gras D, Bocker D, Lunati M, Wellens HJ, Calvert M, Freemantle N, Gervais R, et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF Trial: Procedural success rate and safety. Europace 2007; 9: 516-522.
21. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, et al. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the ontario ICD database. J Am Coll Cardiol 2010; 55: 774-782.
22. Tsai FS, Aronow WS, Devabhaktuni S, Desai H, Kruger A, Lai HM, Frishman WH, et al. Prevalence of complications during implantation and during 38-month follow-up of 1060 consecutive patients with implantable cardioverter-defibrillators. Am J Ther 2010; 17: e8-10.
23. Lever NA, Newall EG, Larsen PD,. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 2007; 9: 1054-1058.
24. Viskin S, Rosso R,. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 2008; 5: 391-393.
25. Manuchehry A, Agusala K, Montevecchi M, Kadish A, Passman R,. Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications. Pacing Clin Electrophysiol 2011; 34: 571-576.